MRNA
Valuation Healthcare · Biotechnology Data as of 2026-06-30P/E Ratio · Metrics
P/E Ratio
-
PEG Ratio
-
Dividend Yield
-
Gross Margin
35.86%
Net Margin
-539.31%
Revenue CAGR 3Y
-25.02%
ROE
-46.27%
ROA
-28.54%
Buyback Yield
-0.25%
Current Ratio
2.29
Magic Earn Yield
-11.24%
Altman Z-Score
4.75
Fair Value River
Score
Valuation 0
Profitability 9
Growth 0
Health 86
Yield 0